-
EP3813878
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3813878
| EP3813878 - ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 03.04.2021 Database last updated on 18.11.2024 | |
| Former | The international publication has been made Status updated on 21.12.2019 | Most recent event Tooltip | 13.05.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states 2seventy bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | [2021/44] |
| Former [2021/18] | For all designated states Bluebird Bio, Inc. 60 Binney Street Cambridge, MA 02142 / US | Inventor(s) | 01 /
FRIEDMAN, Kevin 4 Clover Circle Melrose, Massachusetts 02176 / US | 02 /
PERKINS, Molly Reed 64 Bradlee Road Milton, Massachusetts 02186 / US | [2021/18] | Representative(s) | Forresters IP LLP Skygarden Erika-Mann-Straße 11 80636 München / DE | [2021/18] | Application number, filing date | 19820088.3 | 14.06.2019 | [2021/18] | WO2019US37274 | Priority number, date | US201862685043P | 14.06.2018 Original published format: US 201862685043 P | [2021/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019241686 | Date: | 19.12.2019 | Language: | EN | [2019/51] | Type: | A1 Application with search report | No.: | EP3813878 | Date: | 05.05.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 19.12.2019 takes the place of the publication of the European patent application. | [2021/18] | Search report(s) | International search report - published on: | US | 19.12.2019 | (Supplementary) European search report - dispatched on: | EP | 16.02.2022 | Classification | IPC: | C07K16/28, A61K39/395, C07K16/44, C07K16/42, G01N33/533, G01N33/563, G01N33/68 | [2022/11] | CPC: |
C07K14/7051 (EP,IL);
C07K16/2878 (EP,IL,KR);
C07K16/4258 (US);
A61P35/00 (EP,IL,KR);
C07K16/4208 (EP);
C07K16/4241 (US);
G01N33/533 (EP);
G01N33/563 (EP);
G01N33/56972 (IL,KR,US);
G01N33/583 (US);
G01N33/686 (EP);
A61K2039/505 (KR);
C07K2317/21 (US);
C07K2317/24 (KR,US);
C07K2317/34 (US);
C07K2317/565 (KR);
C07K2317/622 (EP,IL,KR,US);
C07K2319/03 (EP,IL);
|
| Former IPC [2021/18] | A61K39/395, C07K16/28, C07K16/44 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/18] | Title | German: | ANTI-BCMA-CAR-ANTIKÖRPER, KONJUGATE UND VERWENDUNGSVERFAHREN | [2021/18] | English: | ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE | [2021/18] | French: | ANTICORPS CAR ANTI-BCMA, CONJUGUÉS ET PROCÉDÉS D'UTILISATION | [2021/18] | Entry into regional phase | 02.12.2020 | National basic fee paid | 02.12.2020 | Search fee paid | 02.12.2020 | Designation fee(s) paid | 02.12.2020 | Examination fee paid | Examination procedure | 02.12.2020 | Examination requested [2021/18] | 19.09.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 08.06.2021 | Renewal fee patent year 03 | 03.06.2022 | Renewal fee patent year 04 | 12.06.2023 | Renewal fee patent year 05 | 13.05.2024 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2016046724 (BROGDON JENNIFER [US], et al) [Y] 1-15 * ([0622-0626])([0006]) *; | [Y] - BIPULENDU JENA ET AL, "Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials", PLOS ONE, (20130301), vol. 8, no. 3, doi:10.1371/journal.pone.0057838, page e57838, XP055122892 [Y] 1-15 * (p 1, col 2, last lines; p 5, col 1, para 2 to p 6, col 1, first lines; p 11, col 1, para 3)(p 4, col 1, last lines; fig 6)(fig 5) * DOI: http://dx.doi.org/10.1371/journal.pone.0057838 | [A] - JOÃO CONDE ET AL, "Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine", FRONTIERS IN CHEMISTRY, (20140715), vol. 2, doi:10.3389/fchem.2014.00048, XP055206772 [A] 1-15 * para 2p 9, col 2, para 3 to p 10, col 2, * DOI: http://dx.doi.org/10.3389/fchem.2014.00048 | [A] - SMITH E L ET AL, "Development and evaluation of an optimal human single-chain variable fragment-derived BCMA-targeted CAR T cell vector", MOL. THER,, (20180606), vol. 26, no. 6, doi:10.1016/J.YMTHE.2018.03.016, pages 1447 - 1456, XP002795010 [A] 1-15 * the whole document * DOI: http://dx.doi.org/10.1016/j.ymthe.2018.03.016 | [T] - HU YIFEI ET AL, "The Chimeric Antigen Receptor Detection Toolkit", FRONTIERS IN IMMUNOLOGY, Lausanne, CH, (20200811), vol. 11, doi:10.3389/fimmu.2020.01770, ISSN 1664-3224, pages 1 - 16, XP055810131 [T] * the whole document * DOI: http://dx.doi.org/10.3389/fimmu.2020.01770 | [T] - REICHMAN AVINOAM ET AL, "Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells", INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, (20220114), vol. 23, no. 2, doi:10.3390/ijms23020903, page 903, XP055886822 [T] * the whole document * DOI: http://dx.doi.org/10.3390/ijms23020903 | International search | [A]WO2012030982 (BIOGEN IDEC INC [US], et al) [A] 1-3, 15-17, 19-21, 23-25 * entire document *; | [A]WO2014190273 (UNIV TEXAS [US]) [A] 1-3, 15-17, 19-21, 23-25* entire document *; | [A]WO2016014789 (BLUEBIRD BIO INC [US]) [A] 1-3, 15-17, 19-21, 23-25 * entire document *; | [X]US2016046724 (BROGDON JENNIFER [US], et al) [X] 1-3 * entire document *; | [A]WO2017031104 (JANSSEN PHARMACEUTICA NV [BE], et al) [A] 1-3, 15-17, 19-21, 23-25 * entire document * |